Page last updated: 2024-08-24

liarozole and Metastase

liarozole has been researched along with Metastase in 3 studies

Research

Studies (3)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	2 (66.67)	18.2507
2000's	1 (33.33)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Boccardo, F; Brune, D; Bruynseels, J; De Porre, P; Debruyne, FJ; Denis, L; Fradet, Y; Janssens, M; Johansson, JE; Marberger, JM; Murray, R; Rassweiler, J; Tyrrell, C; Vangeneugden, T	1
Abdolell, M; Blackstein, M; Clemons, M; Crump, M; De Coster, R; Goel, R; Goss, PE; Kaizer, L; Marques, R; Nabholtz, JM; Oza, A; Qi, S; Sterns, EE; Strasser, K	1
Denis, L; Mahler, C	1

Reviews

1 review(s) available for liarozole and Metastase

Article	Year
Management of relapsing disease in prostate cancer. Cancer, 1992, Jul-01, Volume: 70, Issue:1 Suppl Topics: Aminoglutethimide; Androgen Antagonists; Antineoplastic Agents; Combined Modality Therapy; Estrogens; Humans; Imidazoles; Ketoconazole; Male; Neoplasm Metastasis; Orchiectomy; Palliative Care; Prostatic Neoplasms; Recurrence	1992

Trials

2 trial(s) available for liarozole and Metastase

Article	Year
Liarozole--a novel treatment approach for advanced prostate cancer: results of a large randomized trial versus cyproterone acetate. Liarozole Study Group. Urology, 1998, Volume: 52, Issue:1 Topics: Aged; Aged, 80 and over; Androgen Antagonists; Cyproterone Acetate; Disease Progression; Humans; Imidazoles; Male; Middle Aged; Neoplasm Metastasis; Neoplasm Staging; Prostate-Specific Antigen; Prostatic Neoplasms; Survival Rate	1998
Liarozole fumarate (R85246): in the treatment of ER negative, tamoxifen refractory or chemotherapy resistant postmenopausal metastatic breast cancer. Breast cancer research and treatment, 2000, Volume: 64, Issue:2 Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Animals; Antineoplastic Agents, Hormonal; Breast Neoplasms; Disease Progression; Dose-Response Relationship, Drug; Drug Resistance, Neoplasm; Estradiol; Female; Humans; Imidazoles; Mammary Neoplasms, Experimental; Middle Aged; Neoplasm Metastasis; Postmenopause; Quality of Life; Rats; Receptors, Estrogen; Tamoxifen; Treatment Outcome	2000

Article

Year

Liarozole--a novel treatment approach for advanced prostate cancer: results of a large randomized trial versus cyproterone acetate. Liarozole Study Group.

Urology, 1998, Volume: 52, Issue:1

Topics: Aged; Aged, 80 and over; Androgen Antagonists; Cyproterone Acetate; Disease Progression; Humans; Imidazoles; Male; Middle Aged; Neoplasm Metastasis; Neoplasm Staging; Prostate-Specific Antigen; Prostatic Neoplasms; Survival Rate

1998

Liarozole fumarate (R85246): in the treatment of ER negative, tamoxifen refractory or chemotherapy resistant postmenopausal metastatic breast cancer.

Breast cancer research and treatment, 2000, Volume: 64, Issue:2

Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Animals; Antineoplastic Agents, Hormonal; Breast Neoplasms; Disease Progression; Dose-Response Relationship, Drug; Drug Resistance, Neoplasm; Estradiol; Female; Humans; Imidazoles; Mammary Neoplasms, Experimental; Middle Aged; Neoplasm Metastasis; Postmenopause; Quality of Life; Rats; Receptors, Estrogen; Tamoxifen; Treatment Outcome

2000